The global AI in drug discovery market is entering a transformative growth phase, reshaping how new therapies are identified, designed, and developed. Valued at US$ 2.1 Bn in 2024, the industry is projected to expand at a remarkable CAGR of 18.4% from 2025 to 2035, crossing US$ 13.2 Bn by the end of 2035. This rapid acceleration reflects a structural shift in pharmaceutical R&D, where...